MedifastMED +1.06%69 PB Ratio is 0.59 as of Jun. 25, 2026, which is 92% below its 10-year median of 7.70. GuruFocus rates MED with a GF Score™ of 69/100 and a GF Value™ of $8.75 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 90 Personal Services companies, Medifast ranks better than 80% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Medifast's share price is $10.47. Medifast's Book Value per Share for the quarter that ended in Mar. 2026 was $17.78. Hence, Medifast's PB Ratio of today is 0.59.
Good Sign:
Medifast Inc stock PB Ratio (=0.58) is close to 10-year low of 0.53.
The historical rank and industry rank for Medifast's PB Ratio or its related term are showing as below:
MED'
s PB Ratio Range Over the Past 10 Years
Min: 0.53 Med: 7.7 Max: 28.93
Current: 0.59
During the past 13 years, Medifast's highest PB Ratio was 28.93. The lowest was 0.53. And the median was 7.70.
MED's PB Ratio is ranked better than 80% of 90
companies
in the Personal Services industry
Industry Median: 1.475
vs MED: 0.59
During the past 12 months, Medifast's average Book Value Per Share Growth Rate was -7.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Medifast was 149.30% per year. The lowest was -39.60% per year. And the median was 11.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medifast PB Ratio Related Terms
Medifast PB Ratio Historical Data
* Premium members only.
The historical data trend for Medifast's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Personal Services subindustry, Medifast's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast PB Ratio vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medifast's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Medifast's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medifast (MED) has a PB Ratio of 0.59 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medifast and its competitors. This is 92% below median its historical median of 7.70. Over the past decade, Medifast's PB Ratio has ranged from 0.53 to 28.93. According to the industry distribution chart, Medifast ranks #18 out of 90 companies in the Personal Services industry, placing it in the top 20%.
Is Medifast's PB Ratio too high?
Medifast's current PB Ratio of 0.59 is 92% below median its 10-year median of 7.70. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 28.93. The Personal Services industry median PB Ratio is 1.48. Medifast's value of 0.59 is 60% below this industry median. Based on the distribution chart, Medifast ranks #18 out of 90 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's PB Ratio compare to RGS and VGES?
According to the Personal Services industry distribution chart, Medifast ranks #18 out of 90 companies for PB Ratio. This places Medifast in the top 20% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.48. Medifast's value of 0.59 is 60% below this benchmark. Historically, Medifast's own PB Ratio has ranged from 0.53 to 28.93 over the past decade. While the company's 10-year median is 7.70 vs. the industry median of 1.48, Medifast has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Personal Services company?
The median PB Ratio among Personal Services companies is 1.48, based on 90 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medifast's current PB Ratio of 0.59 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medifast and its competitors. For the Personal Services industry, the median PB Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current PB Ratio is 0.59, which is 92% below median its own 10-year median of 7.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (MED) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.75, compared to a current price of $10.47 — trading 19.7% above its estimated fair value. The current PB Ratio is 0.59, which is 92% below median its 10-year median of 7.70 and 60% below the Personal Services industry median of 1.48. Medifast's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medifast (MED), the current PB Ratio is 0.59 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of $10.47 is trading 19.7% above its estimated GF Value™ of $8.75.
GuruFocus considers Medifast to be Modestly Overvalued.
Key valuation signals for MED:
PB Ratio: 0.59 (92% below median its 10-year median of 7.70)
GF Value™: $8.75 vs. price of $10.47 (19.7% above fair value)
Industry Position: 60% below the Personal Services median (#18 of 90)
No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
69GF Score
Get the complete analysis for MED
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MED has been successfully added to your 
